Maravai LifeSciences Holdings, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Maravai LifeSciences Holdings, Inc. (MRVI) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $47.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $47.80M, a 6.27% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $51.00M, a 91.75% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $618.40M, a 88242.86% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $700.00K, a 92.55% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $47.80M 10-K · filed 2026-02-26 |
| 2024-12-31 | $51.00M 10-K · filed 2026-02-26 |
| 2023-12-31 | $618.40M 10-K · filed 2025-03-18 |
| 2022-12-31 | $700.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $9.40M 10-K · filed 2023-02-28 |
| 2020-12-31 | $12.10M 10-K · filed 2022-03-01 |